MATILDA STEPHENS: Open Payments
NPI 1003999459 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 40 payments from 16 companies in 2025. Trend: 2023 $616 · 2024 $740 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $250 |
| ABBVIE INC. | 11 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Amgen Inc. | 4 | $68 |
| Viatris Specialty LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
Products named: Ozempic, VRAYLAR, CAPLYTA, YUPELRI, Auvelity, REPATHA, GARDASIL 9, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
